24 results
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
Guideline for the Management ... Practice Guidelines and ... #CHF #guideline ... #ACCAHA2017 #cardiology ... #treatment #algorithm
Algorithm for the Management of Ventricular Tachycardia Electrical Storm
ES diagnosed (≥ 3 episodes of VT/ICD therapies
Algorithm for the ... cardioversion Stable ... of reversible causes ... #Management #VTach ... #morphology #cardiology
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Treatment of Stable ... - Observe and ... Treat underlying cause ... #management #cardiology ... #algorithm
STAGES of CHF (A, B, C, D), however, describe the severity of structural abnormalities that impair
sometimes advanced treatment ... flare ups that cause ... Treatments may include ... #Management #Cardiology ... Stages #ACCAHA #Algorithm
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Treatment Algorithm ... iron #deficiency #CHF ... heartfailure #diagnosis #management ... #algorithm #cardiology ... #treatment #guidelines
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /diagnosis and treatment ... Iron #Deficiency #Management ... Diagnosis #HFrEF #sCHF ... #HeartFailure #Cardiology
Recurrent Polymorphic VT/Torsades de Pointes - Management Algorithm
Drugs that prolong QT interval:
 • Class 1a (quinidine,
Algorithm Drugs ... • Macrolides and ... Hypocalcemia (rarely) Treatment ... #Polymorphic #VTach ... #Algorithm
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
→ Inflammation causes ... functional ID) Treatment ... iron #deficiency #CHF ... heartfailure #diagnosis #management ... #cardiology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
without other cause ... : 33% • Treatment ... : Age>60, CKD, CHF ... CXR with pulmonary ... diagnosis #comparison #table
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
severe bleeding and ... #management #algorithm ... #pharmacology #treatment ... #medications #table ... #decisionaid #cardiology